Erschienen in:
01.06.2010 | Case Report
Acute hepatitis B despite a previous high titer of anti-HBs
verfasst von:
Resat Ozaras, Cem Ar, Seniz Ongoren, Bilgul Mete, Fehmi Tabak, Ali Mert, Recep Ozturk
Erschienen in:
Hepatology International
|
Ausgabe 2/2010
Einloggen, um Zugang zu erhalten
Abstract
Introduction
Loss of HBsAg and development of surface and core antibodies represent clinical cure. However, recent evidence suggests that hepatitis B virus (HBV) persists in a latent state even in those with mounted protective antibodies. After significant immunosuppression, anti-HBs may decrease and HBsAg may reappear (reverse seroconversion). Reverse seroconversion of HBV has been observed in association with hematopoietic stem cell transplantation, renal transplantation, intensive chemotherapy, human immunodeficiency infection, or rituximab usage.
Case report
We present here a case study of a patient with a previous high titer of anti-HBs who later developed HBV reactivation following intensive chemotherapy for leukemia.
Conclusion
We conclude that in immunosuppressed patients with a history of HBV infection may carry a risk for reverse seroconversion and monitoring anti-HBs levels may help recognising this risk.